ESC Premium Access

Impact of LR11 as residual risk on long term clinical outcomes in patients with coronary artery disease treated with statin after first percutaneous coronary intervention

Topic: Inflammation and microcirculation

Congress Presentation

About the speaker

Doctor Norihito Takahashi

Juntendo University Graduate School of Medicine, Tokyo (Japan)
0 follower

6 more presentations in this session

Infarct size in a rat model of STEMI is reduced by interleukin-6 trans-signalling blockade using sgp130fc but not an anti-IL6R monoclonal antibody

Speaker: Doctor M. George (London, GB)


Activation of regulatory T cells in patients with myocardial infarction endows them with enhanced suppressive ability and pro-inflammatory phenotype and function

Speaker: Associate Professor I. Dumitriu (Birmingham, GB)


Inflammasome induced endothelial microparticles impair cellular function in human coronary arterial smooth muscle cells.

Speaker: Mr A. Ackerschott (Bonn, DE)


Markers of gut leakage are associated with cardiovascular events in a high-risk population

Speaker: Doctor A. Awoyemi (Oslo, NO)


Circulating interleukin-8 levels are associated with myocardial injury, left ventricular function and future clinical adverse events in patients with ST-elevation myocardial infarction.

Speaker: Doctor C. Shetelig (Oslo, NO)


Access the full session

CAD: role of inflammation and immunity

Speakers: Doctor N. Takahashi, Doctor M. George, Associate Professor I. Dumitriu, Mr A. Ackerschott, Doctor A. Awoyemi...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb